A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
2010; Springer Science+Business Media; Volume: 29; Issue: 3 Linguagem: Inglês
10.1007/s10637-009-9376-8
ISSN1573-0646
AutoresEvan M. Hersh, Steven O’Day, John D. Powderly, Khuda Dad Khan, Anna C. Pavlick, Lee D. Cranmer, Wolfram E. Samlowski, Geoffrey Nichol, Michael Yellin, Jeffrey S. Weber,
Tópico(s)Immunotherapy and Immune Responses
Referência(s)